Atlas Trials

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

Clinical trial NCT01756729 · TERMINATED

Trial details

NCT number
NCT01756729
Sponsor
NovoCure Ltd.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Recurrent Glioblastoma Multiforme
Start date
2012-12-01
Primary completion
2018-01-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.